 |
| March
25, 2026 |
| Regional
intelligence on Drugs, Diagnostics,
Devices & Digital Health |
|
|
|
* may need subscription to view |
 |
 |
| Boston's
most flexible contract vivarium
lab space: Start with a few study
cages and grow. |
|
Learn More
→ |
|
|
- Addgene and Plasmidsaurus: Strategic
Partnership to Scale Sequencing for Leading
Plasmid Repository
More
- Anumana: Named to Fast Company’s 2026 Most
Innovative Companies Awards More
- Avalyn: Publication Demonstrating
Correlation Between Imaging, Improved Lung
Function, and Quality of Life With AP01 in
Patients With Idiopathic Pulmonary Fibrosis More
- C4 Therapeutics: First Patient Dosed in
Phase 1b Trial of Cemsidomide in Combination With
Elranatamab (ELREXFIO) for Relapsed/Refractory
Multiple Myeloma More
- Cognito Therapeutics and Ochsner Health:
Launch Brain Health Collaboratory to Advance
New Care Models for Alzheimer’s Disease More
- Dana-Farber: Team Develops Open-Access
Predictive Tool to Improve Monitoring of
Smoldering Multiple Myeloma
More
- HKeyBio: Launches HKEY-NHP-onChip 1.1:
World’s First NHP In Vitro Model for
Autoimmune and Allergic Diseases
More
- Karyopharm: Phase 3 SENTRY Trial in
Myelofibrosis Met First Co-Primary Endpoint,
Demonstrating Statistically Significant
Improvement in Spleen Volume Reduction More
More
More*
More*
- Microbot Medical: Strengthens LIBERTY
Endovascular Robotic System Position With
Publication of Its ACCESS PVI Pivotal Study in
Leading Peer-Reviewed Medical Journal More
- NeuroSense: Advances Toward Key Regulatory
Milestones With Strengthened Data Package and
Near-Term Alzheimer's Readout More
- Sarepta: First Clinical Data From siRNA
Pipeline Targeting FSHD1 and DM1 More
- TRIANA Biomedicines: TRI-611 Granted U.S.
FDA Fast Track Designation for Treatment of
ALK Positive Non-small Cell Lung Cancer More
- VIPER Diagnostics: Program Launches as First
Phase of PolyBio Long COVID Cure Initiative
More
- Zealand Pharma: Establishes U.S. Research
Hub in Cambridge, Massachusetts to Expand
Drug Discovery Capabilities and Accelerate
Medicine Creation More
More*
|
|
 |
We
help you focus on the science.
Let Charles River CFO
provide the financial insight you
need.
Flexible fractional and
interim solutions. |
|
Learn More
→ |
|
|
- Apogee Therapeutics: Pricing of $350 Million
Underwritten Public Offering More
- Fractyl Health: Fourth Quarter and Full Year
2025 Financial Results and Business Updates More
- KalVista Pharmaceuticals: Eight Months
Fiscal Year 2025 Financial Results and
Provides Corporate Update More
- Karyopharm: $30 Million Private Placement
With RA Capital More
- More on Quotient and Merck Signing $2.2B
Biotech Collab on Novel Drug Targets in IBD
More*
More*
- More on Shionogi Paying Apnimed $100M for
Joint Venture to Awaken Sleep Disorder Dream
More
More*
More*
- Sernova Biotherapeutics: Close of
Non-Brokered Private Placement Financing
More
|
|
|
 |
Pace®
Life Sciences
The CDMO That Takes You Further.
Your partner for Product
Development, Manufacturing,
Analytical Testing, Regulatory
Consulting & Operational
Support. |
|
Learn More
→ |
|
|
- Insilico’s CEO on AI, Drug Novelty and
Beating China Biotech at R&D More*
- More on Jennifer Jarrett Joining Damora as
CEO More*
- More on Viz.ai, Alnylam Pharmaceuticals
Partnering for Cardiac Amyloidosis Detection More
More*
- Study Suggests Healing Skin Without Scarring
May Be Possible More
- Subscribe to LifeSci Startup for
Updates on US Startups More
- Synthetic DNA Manufacturing Hub Set Up in
Boston by Artis BioSolutions More
|
|
 |
| Life
Sciences Talent and Consulting
Strategist George Quinn Named
Partner, Fractional Talent at
Slone Partners |
|
Learn More
→ |
|
|
- AI in Biotech: The New Frontier for
Leadership & Strategy More
- From Seed to Series C: What
Investors Look for Beyond the Science More
- ICYMI: CEO’s Perspective: Big Moves Come
with Big Responsibility More
- ICYMI: CEO’s Perspective: The High Cost of
Job Hopping More
- ICYMI: Elevating Executive Presence: A
Blueprint for Life Sciences and Biotech
Leaders More
- Idorsia Looks for Another CEO — Again;
Former Jazz Exec Makes a Comeback More*
- M&A in Life Sciences: The Turning Tide –
Why Now is a Strategic Inflection for
Biopharma and Biotech More
- 6 Companies Hiring in Cambridge More
- The Rise of Fractional Talent in Life
Sciences: What to Expect in 2026 More
|
|
|
DISCOVER COMPANIES |
|
Big4Bio: Boston Life Science
Company Directory |
|
Locate a specific company or
explore new companies in life
science. |
|
Explore
our Company Directory
|
Provided courtesy
of
 |
|
|
|
 |
|
|
|
You are
receiving this email because
you signed up for one of our
newsletters at Big4Bio.com,
signed up at one of our
partner or sponsor events,
or given as a gift
subscription by your firm or
organization. Unsubscribe
Big4Bio:Boston,
all rights reserved 2026
© 2026
Big4Bio, a division of
BigBio Communications. All
rights reserved.
|
|
|
|
|
